Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
- Website
- promakhos.com
- City
- Boston
- Country
- United States
- YC batch
- Summer 2021
- Team
- 2 people
- Stage
- Early stage
- AI-native
- No
See it on the Boston mapSource Spot something wrong?
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run promakhos.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Promakhos Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Promakhos Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
